PR Newswire BiotechOriginal article
Northwest Biotherapeutics Announces Keynote Presentation on Harnessing Immunity: A Personalized, Multi-Target Approach to Cancer At the UK National Health Service Annual Oncology Conference
ConferenceDCVaxNeutral
AI Analysis
Summary
Northwest Biotherapeutics announced that Dr. Marnix Bosch, Chief Technical Officer, will present a keynote on personalized, multi-target immunotherapy approaches to cancer at the UK National Health Service Annual Oncology Conference.
Importance:3/10
Sentiment:
0.00
conferencekeynotepersonalized medicineimmunotherapyoncology
Related Companies
Read the original article
Published by PR Newswire Biotech on October 6, 2026 7:00 AM
